Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.

European journal of neurology - 1 Jan 2024

Midaglia Luciana, Rovira Alex, Miró Berta, Río Jordi, Fissolo Nicolás, Castilló Joaquín, Sánchez Alex, Montalban Xavier, Comabella Manuel

Abstract excerpt

BACKGROUND AND PURPOSE: The aim was to evaluate whether magnetic resonance imaging (MRI) phenotypes defined by inflammation and neurodegeneration markers correlate with serum levels of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in relapsing-remitting multiple sclerosis (RRMS) patients; and to explore the role of radiological phenotypes and biomarker levels on treatment response and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Inflammation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Imaging

Share to Multiple Sclerosis

Share to Multiple Sclerosis, Relapsing-Remitting

Share to Neurofilament Proteins

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 37754568
DOI: 10.1111/ene.16077
PMCID: PMC11235849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.PMID 37754568Read ↗

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read ↗

MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changesSemantic proximity Read ↗

Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypeSemantic proximity Read ↗

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosisSemantic proximity Read ↗

MRI phenotypes in MSSemantic proximity Read ↗

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisSemantic proximity Read ↗

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisSemantic proximity Read ↗

Can MRI reveal phenotypes of multiple sclerosis?Semantic proximity Read ↗

MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.Semantic proximity Read ↗

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple SclerosisSemantic proximity Read ↗

Assessing tissue damage in multiple sclerosis: a biomarker approachSemantic proximity Read ↗

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.